Caption Management »

Atrium Therapeutics shares owned by Caption Management

Quarter-by-quarter ownership of Atrium Therapeutics (RNA) shares owned by Caption Management from 13F filings

Historical chart of Caption Management investment in Atrium Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Atrium Therapeutics held by Caption Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atrium Therapeutics by Caption Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.7M 204k 13.37

More positions owned by Caption Management

Meta Platforms Cl A (META)
NVIDIA Corporation (NVDA)
United Therapeutics Corporation (UTHR)
Carvana Cl A Call Option (CVNA)
Warner Bros Discovery Com Ser A Call Option (WBD)
Amazon (AMZN)
Blue Owl Capital Com Cl A (OWL)
Electronic Arts Call Option (EA)
Tesla Motors (TSLA)
Take-Two Interactive Software (TTWO)
Spdr Series Trust State Street Spd Call Option (XBI)
UnitedHealth (UNH)
Netflix (NFLX)
Cg Oncology (CGON)
Microsoft Corporation (MSFT)

View all positions for Caption Management

Top funds holding Atrium Therapeutics

BlackRock
Susquehanna International
RA Capital Management
Vanguard Capital Management
TIG Advisors
Pentwater Capital Management
Sessa Capital IM
Goldman Sachs Group
Farallon Capital Management
Vanguard Portfolio Management
Geode Capital Management
683 Capital Management
Bellevue Group
State Street Corporation
Weiss Asset Management LP[1

View all funds holding Atrium Therapeutics